Gilead Sciences, Inc. (NASDAQ:GILD) announced today that it has received a subpoena from the United States Attorney's Office in San Francisco requesting documents regarding its marketing and medical education programs for Truvada(R) (emtricitabine and tenofovir disoproxil fumarate), Viread(R) (tenofovir disoproxil fumarate) and Emtriva(R) (emtricitabine). Gilead intends to comply with the U.S. Attorney's subpoena and to cooperate in any related government investigation.
That's all you'll get from the news agencies. The Cargo Cult Scientist will go a little further. They were subpoena'd because they _____ and now they have to explain themselves or they will be ______ by the Feds. You heard it here first!
No comments:
Post a Comment